 Laura Saba
Concepts (596)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcohol Drinking | 18 | 2021 | 751 | 2.040 |
Why?
| | Quantitative Trait Loci | 25 | 2025 | 355 | 1.880 |
Why?
| | Ethanol | 16 | 2024 | 585 | 1.430 |
Why?
| | Transcriptome | 9 | 2025 | 879 | 1.340 |
Why?
| | Gene Regulatory Networks | 7 | 2023 | 279 | 1.300 |
Why?
| | Adrenocortical Carcinoma | 7 | 2025 | 63 | 1.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2024 | 484 | 1.140 |
Why?
| | Brain | 20 | 2025 | 2615 | 1.090 |
Why?
| | Adrenal Cortex Neoplasms | 6 | 2025 | 60 | 1.080 |
Why?
| | Quantitative Trait, Heritable | 7 | 2017 | 119 | 1.060 |
Why?
| | Gene Expression Profiling | 16 | 2021 | 1681 | 1.050 |
Why?
| | Rats, Inbred Strains | 7 | 2019 | 362 | 0.960 |
Why?
| | Systems Biology | 3 | 2021 | 59 | 0.920 |
Why?
| | Mitotane | 6 | 2025 | 10 | 0.910 |
Why?
| | Genetic Predisposition to Disease | 13 | 2024 | 2261 | 0.830 |
Why?
| | Liver | 10 | 2024 | 1826 | 0.820 |
Why?
| | Rats | 21 | 2025 | 5199 | 0.790 |
Why?
| | MicroRNAs | 6 | 2019 | 674 | 0.740 |
Why?
| | Sequence Analysis, RNA | 7 | 2022 | 427 | 0.730 |
Why?
| | Polymorphism, Single Nucleotide | 18 | 2025 | 2059 | 0.720 |
Why?
| | Polyadenylation | 1 | 2021 | 40 | 0.700 |
Why?
| | RNA | 6 | 2021 | 881 | 0.700 |
Why?
| | Phenotype | 15 | 2020 | 3039 | 0.690 |
Why?
| | Protein Carbonylation | 7 | 2019 | 55 | 0.690 |
Why?
| | Animals | 60 | 2025 | 34487 | 0.680 |
Why?
| | RNA, Long Noncoding | 2 | 2020 | 178 | 0.670 |
Why?
| | Liver Diseases, Alcoholic | 5 | 2024 | 89 | 0.670 |
Why?
| | Software | 8 | 2025 | 606 | 0.640 |
Why?
| | Drug Tolerance | 4 | 2020 | 83 | 0.620 |
Why?
| | Tunica Media | 1 | 2018 | 37 | 0.580 |
Why?
| | Antineoplastic Agents, Hormonal | 5 | 2025 | 158 | 0.580 |
Why?
| | Tunica Intima | 1 | 2018 | 80 | 0.570 |
Why?
| | Genetic Variation | 5 | 2024 | 933 | 0.570 |
Why?
| | Databases, Genetic | 5 | 2017 | 228 | 0.560 |
Why?
| | Complement C3 | 5 | 2024 | 198 | 0.550 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 118 | 0.550 |
Why?
| | Carotid Stenosis | 1 | 2018 | 85 | 0.540 |
Why?
| | Carotid Arteries | 1 | 2018 | 194 | 0.520 |
Why?
| | Genomics | 6 | 2024 | 714 | 0.510 |
Why?
| | Alcoholism | 8 | 2021 | 764 | 0.500 |
Why?
| | Central Nervous System Depressants | 4 | 2010 | 82 | 0.480 |
Why?
| | Models, Statistical | 1 | 2018 | 621 | 0.460 |
Why?
| | Internet | 6 | 2010 | 613 | 0.430 |
Why?
| | Mustard Gas | 2 | 2025 | 104 | 0.410 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2019 | 755 | 0.410 |
Why?
| | Chemical Warfare Agents | 2 | 2025 | 109 | 0.410 |
Why?
| | Mice | 33 | 2025 | 16574 | 0.400 |
Why?
| | Bayes Theorem | 5 | 2020 | 369 | 0.400 |
Why?
| | Genome-Wide Association Study | 3 | 2025 | 1330 | 0.380 |
Why?
| | Genome | 4 | 2024 | 277 | 0.370 |
Why?
| | Complement Activation | 3 | 2024 | 365 | 0.370 |
Why?
| | Aldehydes | 5 | 2019 | 138 | 0.350 |
Why?
| | Glutathione Transferase | 4 | 2019 | 99 | 0.340 |
Why?
| | Male | 61 | 2025 | 62757 | 0.340 |
Why?
| | Mice, Inbred Strains | 9 | 2020 | 402 | 0.340 |
Why?
| | Oxidative Stress | 6 | 2025 | 1181 | 0.330 |
Why?
| | Health Education | 3 | 2008 | 332 | 0.330 |
Why?
| | Dexamethasone | 3 | 2025 | 339 | 0.320 |
Why?
| | Rats, Wistar | 3 | 2020 | 397 | 0.310 |
Why?
| | Genetic Association Studies | 5 | 2017 | 361 | 0.310 |
Why?
| | Synaptic Transmission | 1 | 2010 | 258 | 0.310 |
Why?
| | Humans | 74 | 2025 | 128019 | 0.300 |
Why?
| | Models, Genetic | 6 | 2025 | 591 | 0.290 |
Why?
| | Nanoparticles | 3 | 2024 | 368 | 0.280 |
Why?
| | Tandem Mass Spectrometry | 5 | 2024 | 452 | 0.280 |
Why?
| | Genotype | 11 | 2025 | 1828 | 0.270 |
Why?
| | Point Mutation | 2 | 2001 | 221 | 0.270 |
Why?
| | Genes, Regulator | 1 | 2006 | 34 | 0.260 |
Why?
| | beta-Thalassemia | 4 | 2013 | 37 | 0.260 |
Why?
| | PTEN Phosphohydrolase | 2 | 2018 | 157 | 0.250 |
Why?
| | Adenylyl Cyclases | 3 | 2012 | 82 | 0.250 |
Why?
| | Gene Expression Regulation | 8 | 2025 | 2508 | 0.250 |
Why?
| | Smoking Prevention | 1 | 2006 | 161 | 0.250 |
Why?
| | Female | 52 | 2024 | 68016 | 0.240 |
Why?
| | Activating Transcription Factor 3 | 1 | 2025 | 5 | 0.240 |
Why?
| | Limbus Corneae | 1 | 2025 | 8 | 0.240 |
Why?
| | Rats, Inbred SHR | 4 | 2018 | 43 | 0.240 |
Why?
| | Activating Transcription Factor 4 | 1 | 2025 | 20 | 0.240 |
Why?
| | Recombination, Genetic | 2 | 2017 | 189 | 0.240 |
Why?
| | Phytochemicals | 1 | 2025 | 12 | 0.240 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2017 | 177 | 0.240 |
Why?
| | Mice, Inbred C57BL | 12 | 2025 | 5268 | 0.240 |
Why?
| | Tea | 1 | 2025 | 20 | 0.240 |
Why?
| | Pituitary-Adrenal System | 3 | 2017 | 144 | 0.230 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2025 | 101 | 0.230 |
Why?
| | Heart Transplantation | 2 | 2021 | 711 | 0.230 |
Why?
| | Cysteine | 1 | 2024 | 182 | 0.210 |
Why?
| | Germ-Line Mutation | 1 | 2024 | 138 | 0.210 |
Why?
| | Analgesia | 1 | 2024 | 92 | 0.210 |
Why?
| | Base Sequence | 6 | 2021 | 2134 | 0.210 |
Why?
| | Corneal Injuries | 1 | 2024 | 41 | 0.210 |
Why?
| | Receptors, GABA-A | 2 | 2018 | 97 | 0.200 |
Why?
| | Immunoglobulins | 2 | 2024 | 157 | 0.200 |
Why?
| | Whole Genome Sequencing | 2 | 2024 | 130 | 0.200 |
Why?
| | Rats, Inbred BN | 3 | 2018 | 53 | 0.200 |
Why?
| | Lysine | 1 | 2024 | 282 | 0.200 |
Why?
| | Dextrans | 2 | 2024 | 82 | 0.200 |
Why?
| | Behavior, Addictive | 2 | 2020 | 81 | 0.190 |
Why?
| | Multifactorial Inheritance | 2 | 2025 | 149 | 0.190 |
Why?
| | Proteome | 3 | 2024 | 430 | 0.190 |
Why?
| | Signal Transduction | 8 | 2025 | 4812 | 0.190 |
Why?
| | Polyethylene Glycols | 2 | 2024 | 598 | 0.190 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 16 | 0.190 |
Why?
| | Leukopenia | 1 | 2021 | 27 | 0.190 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 467 | 0.180 |
Why?
| | Chromatography, Liquid | 5 | 2024 | 377 | 0.180 |
Why?
| | Magnesium Deficiency | 1 | 2020 | 2 | 0.180 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2021 | 120 | 0.180 |
Why?
| | Doxorubicin | 2 | 2024 | 322 | 0.180 |
Why?
| | Myocardium | 2 | 2018 | 967 | 0.180 |
Why?
| | Mycophenolic Acid | 1 | 2021 | 89 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 3 | 2024 | 451 | 0.180 |
Why?
| | Breast Neoplasms | 5 | 2019 | 2131 | 0.180 |
Why?
| | Stem Cells | 1 | 2025 | 577 | 0.170 |
Why?
| | Adult | 30 | 2024 | 35176 | 0.170 |
Why?
| | Hydroxycholesterols | 1 | 2020 | 4 | 0.170 |
Why?
| | Complement System Proteins | 2 | 2024 | 307 | 0.170 |
Why?
| | Trace Elements | 1 | 2020 | 47 | 0.170 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 15 | 0.170 |
Why?
| | Middle Aged | 27 | 2024 | 30812 | 0.170 |
Why?
| | Nicotinamide Mononucleotide | 1 | 2019 | 9 | 0.170 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 2019 | 21 | 0.170 |
Why?
| | Algorithms | 3 | 2023 | 1609 | 0.170 |
Why?
| | Osteoprotegerin | 3 | 2009 | 25 | 0.170 |
Why?
| | Complement Inactivating Agents | 1 | 2020 | 45 | 0.170 |
Why?
| | Liposomes | 2 | 2019 | 168 | 0.170 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 36 | 0.160 |
Why?
| | User-Computer Interface | 1 | 2020 | 147 | 0.160 |
Why?
| | Drosophila | 1 | 2020 | 142 | 0.160 |
Why?
| | Pesticides | 1 | 2019 | 58 | 0.160 |
Why?
| | Genetic Markers | 1 | 2020 | 338 | 0.160 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.160 |
Why?
| | Reflex, Righting | 2 | 2018 | 10 | 0.160 |
Why?
| | Protein Corona | 1 | 2019 | 3 | 0.160 |
Why?
| | Mice, Inbred DBA | 5 | 2019 | 186 | 0.160 |
Why?
| | Opsonin Proteins | 1 | 2019 | 24 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Gene Expression | 3 | 2014 | 1454 | 0.160 |
Why?
| | Cushing Syndrome | 2 | 2010 | 10 | 0.160 |
Why?
| | Eicosanoids | 1 | 2019 | 55 | 0.160 |
Why?
| | Fluorenes | 1 | 2019 | 40 | 0.160 |
Why?
| | Chimera | 1 | 2019 | 59 | 0.160 |
Why?
| | Drosophila Proteins | 1 | 2020 | 187 | 0.150 |
Why?
| | Sex Characteristics | 4 | 2021 | 719 | 0.150 |
Why?
| | Antioxidants | 2 | 2019 | 542 | 0.150 |
Why?
| | Hippocampus | 2 | 2022 | 801 | 0.150 |
Why?
| | Pharmaceutical Preparations | 1 | 2020 | 168 | 0.150 |
Why?
| | Steroid 11-beta-Hydroxylase | 1 | 2018 | 1 | 0.150 |
Why?
| | Hallucinogens | 1 | 2020 | 86 | 0.150 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 17 | 0.150 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 221 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 108 | 0.150 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 97 | 0.150 |
Why?
| | Lymphocytes | 1 | 2020 | 367 | 0.150 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2020 | 202 | 0.150 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 98 | 0.150 |
Why?
| | Cell Degranulation | 1 | 2018 | 42 | 0.150 |
Why?
| | Aged | 16 | 2024 | 21892 | 0.150 |
Why?
| | Angiography, Digital Subtraction | 1 | 2018 | 43 | 0.150 |
Why?
| | Silver | 1 | 2018 | 34 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 108 | 0.140 |
Why?
| | Food Preferences | 2 | 2009 | 112 | 0.140 |
Why?
| | Computational Biology | 3 | 2017 | 595 | 0.140 |
Why?
| | Smoking | 2 | 2020 | 1459 | 0.140 |
Why?
| | Ferrosoferric Oxide | 1 | 2017 | 22 | 0.140 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2018 | 67 | 0.140 |
Why?
| | Receptors, Nicotinic | 1 | 2020 | 323 | 0.140 |
Why?
| | Interleukin-6 | 3 | 2006 | 712 | 0.140 |
Why?
| | Graft Rejection | 1 | 2021 | 557 | 0.140 |
Why?
| | Hepatitis | 1 | 2017 | 47 | 0.140 |
Why?
| | Adipose Tissue, Brown | 1 | 2017 | 51 | 0.140 |
Why?
| | Biomarkers | 6 | 2020 | 3874 | 0.140 |
Why?
| | Monocytes | 1 | 2020 | 546 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2025 | 1343 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 631 | 0.140 |
Why?
| | Web Browser | 1 | 2017 | 12 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 365 | 0.140 |
Why?
| | Mast Cells | 1 | 2018 | 141 | 0.130 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 156 | 0.130 |
Why?
| | Globins | 2 | 1997 | 21 | 0.130 |
Why?
| | Lod Score | 1 | 2016 | 66 | 0.130 |
Why?
| | Cholestasis | 1 | 2019 | 228 | 0.130 |
Why?
| | Opioid-Related Disorders | 1 | 2024 | 480 | 0.130 |
Why?
| | Liver Diseases | 1 | 2019 | 285 | 0.130 |
Why?
| | Seizures | 1 | 2020 | 400 | 0.130 |
Why?
| | Mitochondria | 2 | 2021 | 847 | 0.130 |
Why?
| | Gene Ontology | 1 | 2016 | 48 | 0.130 |
Why?
| | Chromosomes, Mammalian | 1 | 2016 | 26 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 11 | 0.130 |
Why?
| | Pain Threshold | 2 | 2010 | 71 | 0.130 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2016 | 16 | 0.130 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2016 | 21 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 77 | 0.130 |
Why?
| | Depressive Disorder, Major | 2 | 2012 | 344 | 0.130 |
Why?
| | Choice Behavior | 2 | 2014 | 164 | 0.130 |
Why?
| | von Willebrand Factor | 1 | 2016 | 63 | 0.130 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.130 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 256 | 0.120 |
Why?
| | Anxiety | 1 | 2022 | 951 | 0.120 |
Why?
| | Circadian Rhythm | 2 | 2020 | 409 | 0.120 |
Why?
| | beta Karyopherins | 1 | 2015 | 6 | 0.120 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 33 | 0.120 |
Why?
| | Hydrocortisone | 4 | 2012 | 304 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2021 | 710 | 0.120 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2015 | 38 | 0.120 |
Why?
| | Herpesvirus 1, Human | 1 | 2016 | 87 | 0.120 |
Why?
| | Peptides | 1 | 2020 | 910 | 0.120 |
Why?
| | Immune System | 1 | 2016 | 176 | 0.120 |
Why?
| | Darkness | 1 | 2015 | 25 | 0.120 |
Why?
| | Allergens | 1 | 2018 | 381 | 0.120 |
Why?
| | Consensus | 1 | 2018 | 607 | 0.120 |
Why?
| | Diet | 3 | 2008 | 1198 | 0.120 |
Why?
| | Down Syndrome | 1 | 2021 | 469 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 419 | 0.120 |
Why?
| | Neutrophils | 1 | 2020 | 1192 | 0.120 |
Why?
| | Disease Models, Animal | 6 | 2024 | 3936 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2017 | 258 | 0.110 |
Why?
| | Anti-HIV Agents | 1 | 2020 | 749 | 0.110 |
Why?
| | Apoptosis | 2 | 2020 | 2425 | 0.110 |
Why?
| | Proteomics | 4 | 2024 | 1008 | 0.110 |
Why?
| | Ultrasonography | 1 | 2018 | 708 | 0.110 |
Why?
| | Mammography | 2 | 2006 | 146 | 0.110 |
Why?
| | Species Specificity | 4 | 2014 | 568 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2018 | 2337 | 0.110 |
Why?
| | Oxidation-Reduction | 3 | 2024 | 1001 | 0.110 |
Why?
| | LDL-Receptor Related Proteins | 1 | 2013 | 6 | 0.110 |
Why?
| | Chloride Channels | 1 | 1993 | 38 | 0.110 |
Why?
| | Atherosclerosis | 1 | 2018 | 403 | 0.110 |
Why?
| | Iron Overload | 1 | 2013 | 12 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2019 | 1037 | 0.110 |
Why?
| | Cannabis | 1 | 2020 | 426 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2019 | 2757 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 245 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 955 | 0.110 |
Why?
| | Chromosome Mapping | 4 | 2020 | 504 | 0.100 |
Why?
| | Genes | 1 | 1993 | 226 | 0.100 |
Why?
| | Glucocorticoids | 2 | 2009 | 572 | 0.100 |
Why?
| | Database Management Systems | 2 | 2017 | 48 | 0.100 |
Why?
| | Rabbits | 2 | 2025 | 761 | 0.100 |
Why?
| | Blood Pressure | 1 | 2020 | 1711 | 0.100 |
Why?
| | Catalase | 2 | 2017 | 128 | 0.100 |
Why?
| | Metabolomics | 3 | 2025 | 599 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2001 | 384 | 0.100 |
Why?
| | Kidney | 1 | 2019 | 1306 | 0.090 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2012 | 40 | 0.090 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1403 | 0.090 |
Why?
| | Monoamine Oxidase | 1 | 2011 | 27 | 0.090 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3168 | 0.090 |
Why?
| | Inflammation | 4 | 2025 | 2646 | 0.090 |
Why?
| | Iron | 1 | 2013 | 282 | 0.090 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 10 | 0.090 |
Why?
| | Receptors, GABA | 1 | 2010 | 9 | 0.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 395 | 0.090 |
Why?
| | Area Under Curve | 3 | 2019 | 288 | 0.090 |
Why?
| | Rats, Long-Evans | 2 | 2021 | 118 | 0.090 |
Why?
| | Hypertension | 1 | 2020 | 1234 | 0.090 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2010 | 2 | 0.090 |
Why?
| | Bone Density | 2 | 2012 | 474 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1558 | 0.090 |
Why?
| | RNA, Messenger | 5 | 2018 | 2669 | 0.090 |
Why?
| | Colonic Diseases, Functional | 2 | 2000 | 3 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1227 | 0.080 |
Why?
| | Analgesics, Opioid | 2 | 2024 | 886 | 0.080 |
Why?
| | Postmenopause | 1 | 2012 | 348 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 157 | 0.080 |
Why?
| | Morphine | 1 | 2010 | 126 | 0.080 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2009 | 9 | 0.080 |
Why?
| | Cross-Sectional Studies | 5 | 2020 | 5034 | 0.080 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2820 | 0.080 |
Why?
| | Inflammation Mediators | 2 | 2024 | 495 | 0.080 |
Why?
| | RANK Ligand | 1 | 2008 | 27 | 0.080 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 172 | 0.080 |
Why?
| | Breeding | 2 | 2014 | 62 | 0.070 |
Why?
| | Blood Platelets | 1 | 2011 | 376 | 0.070 |
Why?
| | Scleroderma, Systemic | 1 | 2008 | 102 | 0.070 |
Why?
| | Receptors, Glucocorticoid | 1 | 2009 | 148 | 0.070 |
Why?
| | Androgens | 1 | 2009 | 173 | 0.070 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2007 | 52 | 0.070 |
Why?
| | Adrenocorticotropic Hormone | 3 | 2017 | 133 | 0.070 |
Why?
| | Alanine Transaminase | 2 | 2019 | 151 | 0.070 |
Why?
| | Computer-Assisted Instruction | 1 | 2008 | 59 | 0.070 |
Why?
| | Electronic Mail | 1 | 2007 | 60 | 0.070 |
Why?
| | Membrane Proteins | 1 | 1993 | 1105 | 0.070 |
Why?
| | United States | 3 | 2018 | 13785 | 0.070 |
Why?
| | Hepatic Encephalopathy | 1 | 2007 | 19 | 0.070 |
Why?
| | Alcohol Dehydrogenase | 1 | 2006 | 16 | 0.070 |
Why?
| | Adrenal Cortex | 1 | 2006 | 27 | 0.070 |
Why?
| | Cytokine Receptor gp130 | 1 | 2006 | 11 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2024 | 14404 | 0.070 |
Why?
| | Computer Simulation | 2 | 2023 | 936 | 0.060 |
Why?
| | Superoxide Dismutase | 2 | 2019 | 333 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 1 | 2006 | 37 | 0.060 |
Why?
| | Up-Regulation | 2 | 2019 | 822 | 0.060 |
Why?
| | Brain Chemistry | 2 | 2009 | 115 | 0.060 |
Why?
| | HIV Infections | 1 | 2020 | 2703 | 0.060 |
Why?
| | Prednisolone | 1 | 2006 | 82 | 0.060 |
Why?
| | Health Planning Guidelines | 1 | 2006 | 24 | 0.060 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2006 | 127 | 0.060 |
Why?
| | Australia | 1 | 2006 | 243 | 0.060 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2006 | 100 | 0.060 |
Why?
| | Culture | 1 | 2006 | 123 | 0.060 |
Why?
| | Alleles | 2 | 2019 | 842 | 0.060 |
Why?
| | Program Evaluation | 2 | 2007 | 872 | 0.060 |
Why?
| | Bone Resorption | 1 | 2006 | 80 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2006 | 285 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2006 | 101 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2024 | 7029 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2020 | 2258 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2008 | 378 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2021 | 4006 | 0.060 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.060 |
Why?
| | Health Promotion | 2 | 2008 | 716 | 0.060 |
Why?
| | Phosphorylation | 2 | 2019 | 1681 | 0.060 |
Why?
| | Elective Surgical Procedures | 1 | 2006 | 162 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4853 | 0.060 |
Why?
| | ROC Curve | 2 | 2019 | 500 | 0.060 |
Why?
| | Schools | 1 | 2008 | 436 | 0.060 |
Why?
| | Exercise | 2 | 2006 | 1917 | 0.060 |
Why?
| | Acetylation | 1 | 2024 | 242 | 0.060 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2006 | 135 | 0.060 |
Why?
| | Molecular Sequence Annotation | 1 | 2024 | 88 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 1993 | 1048 | 0.050 |
Why?
| | Oxycodone | 1 | 2024 | 42 | 0.050 |
Why?
| | Sports | 1 | 2006 | 221 | 0.050 |
Why?
| | Case-Control Studies | 4 | 2017 | 3324 | 0.050 |
Why?
| | Environmental Exposure | 1 | 2008 | 458 | 0.050 |
Why?
| | Albumins | 1 | 2023 | 101 | 0.050 |
Why?
| | Cornea | 1 | 2024 | 116 | 0.050 |
Why?
| | Actin Cytoskeleton | 1 | 2024 | 101 | 0.050 |
Why?
| | Leptin | 1 | 2004 | 218 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 185 | 0.050 |
Why?
| | Adolescent | 6 | 2019 | 20158 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2025 | 519 | 0.050 |
Why?
| | Microarray Analysis | 2 | 2015 | 120 | 0.050 |
Why?
| | Mass Screening | 2 | 2010 | 1145 | 0.050 |
Why?
| | Feces | 1 | 2025 | 435 | 0.050 |
Why?
| | Health Behavior | 1 | 2007 | 740 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 558 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2008 | 1272 | 0.050 |
Why?
| | Actins | 1 | 2024 | 401 | 0.050 |
Why?
| | Young Adult | 4 | 2024 | 12281 | 0.050 |
Why?
| | Prostatic Neoplasms | 1 | 2009 | 1011 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2042 | 0.050 |
Why?
| | Curriculum | 1 | 2008 | 909 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 815 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2001 | 92 | 0.050 |
Why?
| | Blotting, Western | 2 | 2015 | 1169 | 0.040 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2020 | 4 | 0.040 |
Why?
| | Killer Cells, Natural | 1 | 2004 | 426 | 0.040 |
Why?
| | Time Factors | 4 | 2019 | 6479 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2006 | 1356 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2021 | 60 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2001 | 266 | 0.040 |
Why?
| | Risk Factors | 4 | 2019 | 9696 | 0.040 |
Why?
| | Rats, Inbred F344 | 1 | 2001 | 251 | 0.040 |
Why?
| | Multiple Sclerosis | 1 | 2006 | 435 | 0.040 |
Why?
| | Oxysterols | 1 | 2020 | 2 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 368 | 0.040 |
Why?
| | Cytomegalovirus | 1 | 2021 | 152 | 0.040 |
Why?
| | Magnesium | 1 | 2020 | 150 | 0.040 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 36 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2020 | 140 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 33 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2020 | 67 | 0.040 |
Why?
| | Indians, North American | 1 | 2006 | 599 | 0.040 |
Why?
| | DNA Primers | 1 | 2001 | 509 | 0.040 |
Why?
| | Carbon | 1 | 2021 | 207 | 0.040 |
Why?
| | Italy | 3 | 1997 | 97 | 0.040 |
Why?
| | Catheterization | 1 | 2000 | 171 | 0.040 |
Why?
| | Metabolic Syndrome | 2 | 2017 | 338 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 59 | 0.040 |
Why?
| | Protective Agents | 1 | 2019 | 36 | 0.040 |
Why?
| | Transplant Recipients | 1 | 2021 | 152 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2019 | 87 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2019 | 86 | 0.040 |
Why?
| | Emtricitabine | 1 | 2020 | 168 | 0.040 |
Why?
| | Substance Abuse Detection | 1 | 2020 | 73 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2019 | 147 | 0.040 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2019 | 160 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2006 | 1619 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 187 | 0.040 |
Why?
| | Benchmarking | 1 | 2020 | 175 | 0.040 |
Why?
| | Sample Size | 1 | 2019 | 115 | 0.040 |
Why?
| | Colitis, Ulcerative | 1 | 2000 | 113 | 0.040 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 81 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 45 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 396 | 0.040 |
Why?
| | Cerebellum | 1 | 2001 | 217 | 0.040 |
Why?
| | Sensation | 1 | 1999 | 50 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 163 | 0.040 |
Why?
| | Caspase 3 | 1 | 2019 | 229 | 0.040 |
Why?
| | Lysosomes | 1 | 2019 | 135 | 0.040 |
Why?
| | Normal Distribution | 1 | 2018 | 21 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 331 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 39 | 0.040 |
Why?
| | Receptors, AMPA | 1 | 2020 | 133 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2012 | 248 | 0.040 |
Why?
| | Protons | 1 | 2019 | 80 | 0.040 |
Why?
| | Colorado | 3 | 2020 | 4369 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 490 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 15 | 0.040 |
Why?
| | Metyrapone | 1 | 2018 | 2 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 312 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 41 | 0.040 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 16 | 0.040 |
Why?
| | Dinitrobenzenes | 1 | 2018 | 5 | 0.040 |
Why?
| | Cardiovascular Diseases | 2 | 2008 | 1994 | 0.040 |
Why?
| | Pregnancy | 3 | 2020 | 6355 | 0.040 |
Why?
| | Bacteria | 1 | 2025 | 812 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 79 | 0.040 |
Why?
| | Dronabinol | 1 | 2020 | 167 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 57 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 164 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 268 | 0.040 |
Why?
| | Receptors, IgE | 1 | 2018 | 44 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 2041 | 0.040 |
Why?
| | Abdominal Pain | 1 | 1999 | 144 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 175 | 0.040 |
Why?
| | Magnetite Nanoparticles | 1 | 2017 | 26 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 26 | 0.040 |
Why?
| | Thioredoxins | 1 | 2017 | 28 | 0.040 |
Why?
| | Fetal Development | 1 | 2020 | 283 | 0.040 |
Why?
| | Organ Specificity | 1 | 2018 | 290 | 0.040 |
Why?
| | DNA Damage | 1 | 2019 | 363 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2024 | 1175 | 0.030 |
Why?
| | Heterozygote | 3 | 1994 | 267 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 67 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2019 | 796 | 0.030 |
Why?
| | Crigler-Najjar Syndrome | 1 | 1997 | 2 | 0.030 |
Why?
| | Protein Structure, Secondary | 1 | 2018 | 340 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 327 | 0.030 |
Why?
| | Glucuronosyltransferase | 1 | 1997 | 13 | 0.030 |
Why?
| | Tuberculosis | 1 | 2020 | 271 | 0.030 |
Why?
| | Metal Nanoparticles | 1 | 2018 | 82 | 0.030 |
Why?
| | Camptothecin | 1 | 2017 | 106 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2007 | 2509 | 0.030 |
Why?
| | Solubility | 2 | 2008 | 232 | 0.030 |
Why?
| | Cell Survival | 1 | 2020 | 1073 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 319 | 0.030 |
Why?
| | Surface Properties | 1 | 2017 | 393 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 619 | 0.030 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2017 | 185 | 0.030 |
Why?
| | Prospective Studies | 3 | 2017 | 7035 | 0.030 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 200 | 0.030 |
Why?
| | Exons | 2 | 1997 | 338 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2016 | 72 | 0.030 |
Why?
| | Genetic Linkage | 2 | 2007 | 299 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 59 | 0.030 |
Why?
| | Medication Adherence | 1 | 2020 | 559 | 0.030 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 177 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2019 | 504 | 0.030 |
Why?
| | Autophagy | 1 | 2018 | 265 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 95 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2015 | 7 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 649 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 682 | 0.030 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 15 | 0.030 |
Why?
| | Codon | 2 | 1992 | 86 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1870 | 0.030 |
Why?
| | Heart | 1 | 2018 | 637 | 0.030 |
Why?
| | Genetic Testing | 1 | 1997 | 428 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2019 | 842 | 0.030 |
Why?
| | Histones | 1 | 2019 | 585 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 816 | 0.030 |
Why?
| | Glutathione | 1 | 2016 | 340 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 182 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 369 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 377 | 0.030 |
Why?
| | Saliva | 2 | 2006 | 207 | 0.030 |
Why?
| | Gene Frequency | 1 | 2015 | 504 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 419 | 0.030 |
Why?
| | Triglycerides | 1 | 2016 | 523 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1690 | 0.030 |
Why?
| | Chelation Therapy | 1 | 2013 | 11 | 0.030 |
Why?
| | Iron Chelating Agents | 1 | 2013 | 17 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2736 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2017 | 730 | 0.030 |
Why?
| | Mice, Transgenic | 2 | 2010 | 2066 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1264 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1896 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2105 | 0.030 |
Why?
| | Glucose | 1 | 2017 | 983 | 0.020 |
Why?
| | Thalassemia | 1 | 1992 | 6 | 0.020 |
Why?
| | Exome | 1 | 2013 | 220 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3009 | 0.020 |
Why?
| | Child | 3 | 2008 | 20636 | 0.020 |
Why?
| | Transferrin | 1 | 2011 | 42 | 0.020 |
Why?
| | Blood Cell Count | 1 | 2011 | 52 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1689 | 0.020 |
Why?
| | Placenta | 1 | 2018 | 716 | 0.020 |
Why?
| | Neurons | 1 | 2020 | 1445 | 0.020 |
Why?
| | DNA | 3 | 1994 | 1392 | 0.020 |
Why?
| | Liver Function Tests | 1 | 2011 | 107 | 0.020 |
Why?
| | Reference Standards | 1 | 2011 | 168 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 471 | 0.020 |
Why?
| | Obesity | 1 | 2004 | 2859 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 11 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 23 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 40 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 142 | 0.020 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 236 | 0.020 |
Why?
| | Contraindications | 1 | 2010 | 87 | 0.020 |
Why?
| | Antisocial Personality Disorder | 1 | 2011 | 162 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1993 | 312 | 0.020 |
Why?
| | Logistic Models | 2 | 2006 | 1975 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2010 | 83 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 301 | 0.020 |
Why?
| | Blood Proteins | 1 | 2011 | 239 | 0.020 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2009 | 8 | 0.020 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2009 | 9 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 5688 | 0.020 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2010 | 83 | 0.020 |
Why?
| | Corticosterone | 1 | 2010 | 214 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 1942 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 37 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 2008 | 52 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2017 | 10110 | 0.020 |
Why?
| | New Mexico | 1 | 2008 | 59 | 0.020 |
Why?
| | Social Marketing | 1 | 2008 | 13 | 0.020 |
Why?
| | Rural Health | 1 | 2008 | 70 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2008 | 273 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 940 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2008 | 169 | 0.020 |
Why?
| | Pituitary Function Tests | 1 | 2007 | 3 | 0.020 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2007 | 8 | 0.020 |
Why?
| | Sunlight | 1 | 2008 | 69 | 0.020 |
Why?
| | Fruit | 1 | 2008 | 131 | 0.020 |
Why?
| | Vegetables | 1 | 2008 | 147 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2009 | 368 | 0.020 |
Why?
| | Adrenal Glands | 1 | 2007 | 70 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 572 | 0.020 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 1 | 2006 | 23 | 0.020 |
Why?
| | Myoglobin | 1 | 2006 | 13 | 0.020 |
Why?
| | Stochastic Processes | 1 | 2007 | 66 | 0.020 |
Why?
| | Acetaldehyde | 1 | 2006 | 17 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2006 | 30 | 0.020 |
Why?
| | Genetic Carrier Screening | 2 | 1997 | 25 | 0.020 |
Why?
| | Pituitary Gland | 1 | 2007 | 148 | 0.020 |
Why?
| | Osteoclasts | 1 | 2006 | 42 | 0.020 |
Why?
| | Electrophysiology | 1 | 2006 | 204 | 0.020 |
Why?
| | Angiography | 1 | 2007 | 192 | 0.020 |
Why?
| | Hip Prosthesis | 1 | 2006 | 36 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2006 | 197 | 0.020 |
Why?
| | Hormones | 1 | 2006 | 140 | 0.020 |
Why?
| | Bone and Bones | 1 | 2008 | 298 | 0.020 |
Why?
| | Reminder Systems | 1 | 2007 | 174 | 0.020 |
Why?
| | Phosphorus | 1 | 2006 | 93 | 0.020 |
Why?
| | Educational Measurement | 1 | 2008 | 257 | 0.020 |
Why?
| | Educational Status | 1 | 2008 | 470 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2006 | 281 | 0.020 |
Why?
| | Physical Endurance | 1 | 2006 | 262 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2006 | 189 | 0.010 |
Why?
| | Lactic Acid | 1 | 2006 | 294 | 0.010 |
Why?
| | Pedigree | 2 | 1997 | 485 | 0.010 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 54 | 0.010 |
Why?
| | Risk | 1 | 2007 | 850 | 0.010 |
Why?
| | Electromyography | 1 | 2006 | 380 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2004 | 82 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2004 | 316 | 0.010 |
Why?
| | Neoplasms | 1 | 2018 | 2460 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2004 | 216 | 0.010 |
Why?
| | Anthropometry | 1 | 2004 | 204 | 0.010 |
Why?
| | Dietary Carbohydrates | 1 | 2004 | 150 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 2006 | 758 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 1934 | 0.010 |
Why?
| | Interleukin-2 | 1 | 2004 | 434 | 0.010 |
Why?
| | Vitamin D | 1 | 2006 | 380 | 0.010 |
Why?
| | Dietary Fats | 1 | 2004 | 301 | 0.010 |
Why?
| | Odds Ratio | 1 | 2004 | 1018 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5378 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3371 | 0.010 |
Why?
| | Patient Selection | 1 | 2004 | 658 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2004 | 1288 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 2008 | 818 | 0.010 |
Why?
| | Calcium | 1 | 2006 | 1182 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 2006 | 756 | 0.010 |
Why?
| | Viscera | 1 | 1999 | 16 | 0.010 |
Why?
| | Child, Preschool | 2 | 2008 | 10378 | 0.010 |
Why?
| | Research Design | 1 | 2004 | 1034 | 0.010 |
Why?
| | Age Factors | 1 | 2006 | 3100 | 0.010 |
Why?
| | Psychological Tests | 1 | 1999 | 130 | 0.010 |
Why?
| | Pain Measurement | 1 | 2000 | 478 | 0.010 |
Why?
| | Cytokines | 1 | 2006 | 1984 | 0.010 |
Why?
| | Perception | 1 | 2000 | 336 | 0.010 |
Why?
| | Registries | 1 | 2004 | 1873 | 0.010 |
Why?
| | Genetics, Population | 1 | 1997 | 200 | 0.010 |
Why?
| | Prenatal Diagnosis | 1 | 1997 | 190 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 2260 | 0.010 |
Why?
| | Mutation | 2 | 1997 | 3682 | 0.010 |
Why?
| | Homozygote | 1 | 1994 | 192 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2000 | 2703 | 0.010 |
Why?
| | Frameshift Mutation | 1 | 1992 | 31 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 328 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1992 | 1020 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 1999 | 5353 | 0.000 |
Why?
| | Infant | 1 | 1997 | 8912 | 0.000 |
Why?
|
|
Saba's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|